drugset / Trial / NCT06878599

Intratympanic Injection of Dexamethasone With Hyaluronic Acid in Treatment of Sudden Sensorineural Hearing Loss

NCT06878599

Phase 4 Not yet recruiting 70 enrolled Assiut University
RandomizedParallel-groupOpen-labelTreatment

Summary

* To evaluate efficacy of intratympanic injection of dexamethasone and hyaluronic acid mixture as a treatment modality in cases of sudden sensorineural hearing loss (SSNHL). * To compare outcomes of intratympanic injection of dexamethasone and hyaluronic acid mixture to dexamethasone alone in treatment of SSNHL.

Timeline

Start
2025-05-01
Primary completion
2027-10
Completion
2028-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule Other
Subject Hyaluronic Acid Other / unclassified Other